Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients

NCT02802228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Portal Hypertension
Liver Cirrhosis

Interventions

DRUG: Ifetroban
DRUG: Placebo

Sponsor

Cumberland Pharmaceuticals